A Multi-center Cohort Study to Evaluate the Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric Cancer
Latest Information Update: 17 Jan 2025
Price :
$35 *
At a glance
- Drugs Trastuzumab-deruxtecan
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 17 Jan 2025 New trial record